Harmaline and related compounds have been shown to be potent inhibitors of monoamine oxidase effecting 50 per cent inhibition of serotonin metabolism at 1O-EM. Inhibition is reversible both in vitro and in vivo. Procedures have been presented for evaluating the effectiveness of monoamine oxidase inhibitors both in vitro and in vivo.